ATL transducer gets PMA

Article

ATL Ultrasound has received supplemental premarket approval (PMA) from the Food and Drug Administration to market a new scanhead, L12-5, for breast imaging applications on the company's HDI 3000 scanner. The transducer features a new design that improves

ATL Ultrasound has received supplemental premarket approval (PMA) from the Food and Drug Administration to market a new scanhead, L12-5, for breast imaging applications on the company's HDI 3000 scanner. The transducer features a new design that improves near-field focus and image quality, according to the Bothell, WA, vendor. ATL has also received PMAs for breast imaging applications with its Ultramark 9 HDI and HDI 3000 systems.

Newsletter

Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.

Recent Videos
Can the Emerging InteleHeart Platform Facilitate Improved Efficiency with Cardiology and Radiology?
Diagnostic Imaging’s Weekly Scan: October 5 — October 11
Current Insights on Interoperability, Enterprise Imaging and AI Integration in Radiology
© 2025 MJH Life Sciences

All rights reserved.